Literature DB >> 8147676

Sexual dysfunction with antihypertensive drugs.

L M Prisant1, A A Carr, P B Bottini, D S Solursh, L P Solursh.   

Abstract

The relationship of antihypertensive drugs have a long history of association with sexual dysfunction; however, this relationship is poorly documented. There appears to be a higher rate of sexual dysfunction in untreated hypertensive men compared with normotensive men. Sexual dysfunction increases with age and is associated with physical and emotional symptoms. There are few studies assessing sexual dysfunction with female and African-American hypertensive patients. Sexual dysfunction is associated with impairment of quality of life and noncompliance. Since group data may hide individual drug effects, baseline data should be collected on all patients before initiating therapy with any antihypertensive agent. Although questionnaires may not provide objective information on sexual dysfunction, the response rate to direct questioning may be less than the response rate on a questionnaire and may be affected by the gender or race of the interviewer. Research protocols using a double-blind, placebo-controlled design should assess sexual dysfunction in men and women in a standardized fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8147676

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

1.  Sexual dysfunction in female hypertensives.

Authors:  Basil N Okeahialam; Ndudim C Obeka
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

Review 2.  Cost-effective therapy for hypertension.

Authors:  W Barrie
Journal:  West J Med       Date:  1996-04

Review 3.  Phosphodiesterase-5 inhibitors and their hemodynamic effects.

Authors:  L Michael Prisant
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

4.  Patients' responses to risk information about the benefits of treating hypertension.

Authors:  D Misselbrook; D Armstrong
Journal:  Br J Gen Pract       Date:  2001-04       Impact factor: 5.386

Review 5.  Cardiovascular safety of sildenafil.

Authors:  Diane Tran; Laurence Guy Howes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  Sexual dysfunction in patients with hypertension: implications for therapy.

Authors:  Carlos M Ferrario; Pavel Levy
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

7.  Arterial elasticity and erectile dysfunction in hypertensive men.

Authors:  L Michael Prisant; Don H Loebl; Jennifer L Waller
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

8.  Antihypertensive pharmacobezoar.

Authors:  L Michael Prisant; Vernon C Spaulding
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-04       Impact factor: 3.738

9.  Sacubitril/Valsartan Improves Sexual Function and Fibrosis of the Clitoral and Vaginal Tissues in Female Spontaneously Hypertensive Rats.

Authors:  Chenchen Zhuang; Wenjuan Wang; Runmin Sun; Miaomiao Qi; Jing Yu
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

10.  Should beta blockers be used in the treatment of hypertension in the elderly?

Authors:  L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.